See also this year's filing and all EDGAR filings for this company.
PDF Report 0001347613_2013_Synergy_Pharmaceuticals_LLC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | Similarly named company. Duplicate? | None | {'details': [{'other_company': 'Horizon Pharmaceutical LLC', 'shared_tokens': {'llc'}}]} |
| warning | NetIncome node detected by IncomeLoss name heuristic | input.sec.calculation_linkbase.edgar_model_mapping | {} |
| warning | Missing logo | subcommand.report | {} |
| warning | Ignoring company because Expenses is zero | pre-agg | {'balance_sheet': {'company_id': '0001347613', 'EntityCommonStockSharesOutstanding': 90182115, 'Assets': 72558000, 'AssetsCurrent': 71875000, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 17210000, 'LiabilitiesAndStockholdersEquity': 72558000, 'LiabilitiesCurrent': 15676000, 'LiabilitiesNoncurrent': 0, 'NetIncome': -62124000, 'PropertyPlantAndEquipmentNet': 589000, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 0, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 94000, 'remainder_ComprehensiveNetIncome': 0, 'remainder_Expenses': 0, 'remainder_Liabilities': 1534000, 'remainder_LiabilitiesAndStockholdersEquity': 55348000, 'remainder_NetIncome': -62124000, 'remainder_Revenues': 0, 'obs_EconomicCapitalRatio': nan}} |
Graph
Absolute values for 0001347613, Synergy Pharmaceuticals LLC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 34,049,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 30,000 |
| 3 | remainder_Assets | 3,326,000 |
| 4 | LiabilitiesCurrent | 7,315,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 5,258,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,941,000 |
| 9 | ResearchAndDevelopmentExpense | 29,294,000 |
| 10 | remainder_Expenses | 29,157,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -1,209,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 37,405,000 |
| 1 | Liabilities | 12,573,000 |
| 2 | Expenses | 66,392,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 24,832,000 |
| 5 | NetIncome | -67,601,000 |
| 6 | ComprehensiveNetIncome | -67,601,000 |
| 7 | BaseVar | 58,789,500 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.539 |
| 9 | EconomicCapitalRatio | 1.38 |
Edgar->Model Mapping
Feature Distribution
Change over Time
